Company Encyclopedia
View More
name
HONLIV HEALTH
09906.HK
Honliv Healthcare Management Group Company Limited engages in the ownership, operation, and management of hospitals in the People’s Republic of China. It provides integrated medical and pharmaceutical services; hospital management services; and maternal and infant nursing services. The company also operates as a pharmaceutical wholesaler. In addition, it operates and manages Henan Honliv Hospital.
34.20 B
09906.HKMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
C
Health Care FacilitiesIndustry
Industry Ranking9/18
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE1.87%C
    • Profit Margin1.49%C
    • Gross Margin13.21%D
  • Growth ScoreD
    • Revenue YoY-12.89%E
    • Net Profit YoY-69.34%E
    • Total Assets YoY-8.19%E
    • Net Assets YoY0.62%C
  • Cash ScoreC
    • Cash Flow Margin6711.07%A
    • OCF YoY-12.89%E
  • Operating ScoreB
    • Turnover0.74B
  • Debt ScoreB
    • Gearing Ratio37.32%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    "Performance" HONLIV HEALTH turned a profit into a loss of 673,000 RMB in half a year

    HONLIV HEALTH announced its interim results for the period ending June this year, with a revenue of RMB 347 million, a year-on-year decrease of 16.5%. It reported a loss of RMB 673,000, compared to a profit of RMB 20.042 million in the same period last year. No dividend was declared

    AASTOCKS·
    HK
    09906
    0.00%
    AASTOCKS·
    HK
    09906
    0.00%

    HONLIV HEALTH released its interim results, with a loss attributable to shareholders of RMB 673,000, turning from profit to loss year-on-year

    According to the Zhitong Finance APP, HONLIV HEALTH released its mid-term results for 2025, with revenue of 347 million yuan (RMB, the same below), a year-on-year decrease of 16.5%; the loss attributable to shareholders was 673,000 yuan, compared to a profit attributable to shareholders of 20.042 million yuan in the same period last year, turning from profit to loss year-on-year

    Zhitong·
    HK
    09906
    0.00%
    Zhitong·
    HK
    09906
    0.00%

    "Profit Warning" HONLIV HEALTH forecasts a loss of no more than 2 million RMB in the first half of the year

    HONLIV HEALTH issued a profit warning, expecting a net loss of no more than 2 million RMB for the six months ending in June, compared to a net profit of 20 million RMB for the same period last year. The shift from profit to loss is mainly due to a decrease in demand for inpatient medical services leading to reduced revenue; and based on the settlement results of the insurance plan, the actual settlement rate is lower than the estimated settlement rate, resulting in a decrease in inpatient service revenue for the current period, as well as a further reduction in the estimated settlement rate for inpatient service revenue covered by the plan

    AASTOCKS·
    HK
    09906
    0.00%
    AASTOCKS·
    HK
    09906
    0.00%

    HONLIV HEALTH issued a profit warning, expecting a mid-term net loss attributable to shareholders of no more than 2 million yuan, a year-on-year loss compared to profit

    HONLIV HEALTH issued a profit warning, expecting a net loss attributable to shareholders of no more than 2 million yuan for the interim period ending June 30, 2025, a turnaround from a net profit of approximately 20 million yuan for the same period in 2024. The board of directors pointed out that the loss is mainly due to a decrease in demand for inpatient medical services and a settlement rate of public health insurance plans lower than expected, resulting in a decline in revenue

    Zhitong·
    HK
    09906
    0.00%
    Zhitong·
    HK
    09906
    0.00%

    HONLIV HEALTH announced its 2024 performance, with profit attributable to owners of the company at 31.151 million yuan, a year-on-year decrease of 18.7%

    According to the Zhitong Finance APP, HONLIV HEALTH announced its 2024 performance, with revenue of approximately 769 million yuan, a year-on-year increase of 1.1%. The profit attributable to the company's owners was 31.151 million yuan, a year-on-year decrease of 18.7%. The basic and diluted earnings per share were 0.06 yuan. The announcement stated that the revenue growth was mainly due to the increase in income from treatment and comprehensive medical services as well as pharmaceutical sales

    Zhitong·
    HK
    09906
    0.00%
    Zhitong·
    HK
    09906
    0.00%
    © 2025 Longbridge｜Disclaimer